BCMA-CD19 cCAR T for the Treatment of Refractory Lupus

Clinical trial NCT07328581 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07328581
Sponsor: iCell Gene Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)

Start date: 2026-01-01
Primary completion: 2028-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.